Enter assignee name

% Expired Patents = 9.1

Forward Citations = 34

Loading Chart...

3 inventors (with patents filed for the assignee):

Gary D Glick (11 out of 66 patents)

Luigi Franchi (8 out of 13 patents)

Giancarlo Santus (2 out of 28 patents)

11 patents: Sort by Forward Citations

1. 11793777 - Methods and compositions for treating conditions associated with an abnormal inflammatory response (2023-10-24),

2. 11744812 - Methods of treatment (2023-09-05),

3. 11564896 - Methods of treatment (2023-01-31),

4. 10980756 - Methods of treatment (2021-04-20),

5. 10912746 - Methods and compositions for treating conditions associated with an abnormal inflammatory response (2021-02-09),

6. 10905666 - Methods and compositions for treating conditions associated with an abnormal inflammatory response (2021-02-02),

7. 10849867 - Methods and compositions for treating conditions associated with an abnormal inflammatory response (2020-12-01),

8. 10799468 - Methods and compositions for treating conditions associated with an abnormal inflammatory responses (2020-10-13),

9. 10772854 - Methods and compositions for treating conditions associated with an abnormal inflammatory response (2020-09-15),

10. 10744103 - Methods and compositions for treating conditions associated with an abnormal inflammatory responses (2020-08-18),

11. 10292951 - Methods and compositions for treating conditions associated with an abnormal inflammatory responses (2019-05-21),

First Wave Bio, Inc. is a biopharmaceutical company based in Ann Arbor, Michigan, focused on developing innovative therapies for patients with gastrointestinal diseases. The company specializes in the research and development of novel drug formulations aimed at addressing unmet medical needs in this domain. By leveraging advanced drug delivery technologies, First Wave Bio aims to enhance treatment efficacy and improve patient outcomes, positioning itself as a key player in the biopharmaceutical landscape.

Profile summary based on public USPTO records.